Sustainability & Climate

A new partnership combines Edge AI processing with long-range Wi-Fi HaLow, promising to simplify and scale intelligent device deployments for enterprise.

Fewer than 10% of hospitals achieve Magnet status. City of Hope just earned it twice. Discover what this rare honor means for patient safety and nursing.

With a fresh funding series, Clipto.AI is pioneering a privacy-first future where powerful AI processes your sensitive content directly on your device.

Following a period of mixed financials, Neogen appoints new leaders to drive innovation and growth in its critical global food safety division.

DIETL's acquisition of four specialists, including a rare US freeport, signals a major consolidation in the elite world of fine art logistics.

A new initiative is tackling the fear and distrust that costs patients their health and the system trillions. Is 'cognitive safety' healthcare's next frontier?

With a hot obesity pipeline and a key neurology asset, Nxera Pharma's J.P. Morgan talk is a crucial test of its plan for global leadership.

With surging revenue for its cholesterol drugs and new guideline backing, Esperion outlines its strategy for profitability and pipeline expansion.

A new partnership aims to accelerate driver safety tech in next-gen vehicles, merging AI monitoring with a fortress-like operating system.

As the HYROX fitness race explodes in popularity, MOVATI Athletic has certified all five Ottawa clubs, positioning the city as a hub for hybrid athletes.

Routeware appoints proven tech leaders Jeremy Collins and Ray Greer to drive its next growth phase, focusing on platform modernization and market leadership.

Vanadium giant Largo Inc. inks a binding term sheet to sell a decade's worth of byproduct, a move that could boost its finances and green credentials.

With blockbuster sales from VYJUVEK, Krystal Biotech heads to J.P. Morgan with investors eager for news on its global growth and ambitious pipeline.

Weight Watchers now offers the new Wegovy pill, a needle-free option, betting its future on combining powerful GLP-1 drugs with its classic support.

China's ETF market had a record 2025, fueled by AI breakthroughs and state support. A look at the boom, the leaders, and the risks ahead.

The new over-the-counter molecular test could deliver results in 30 minutes, aiming to revolutionize STI diagnostics and tap into a $1.5B market.

South Korea's Curogen secures major national funding and targets global partners at the JP Morgan conference, advancing novel therapies for IBD and HS.

Gyre Therapeutics secures a pivotal conditional approval pathway in China for its novel liver fibrosis drug, offering hope for millions of hepatitis B patients.

A new partnership aims to unlock the potential of a next-gen obesity drug by pairing it with advanced delivery tech to overcome historical hurdles.

Ingevity divests its North Charleston CTO assets to Mainstream Pine Products, sharpening its focus on high-margin activated carbon and advanced polymers.